JPMorgan upgraded IGM Biosciences (IGMS) to Neutral from Underweight without a price target The firm says that with the company announcing ...
Staff cuts could leave IGM Biosciences with fewer than 55 employees. The company is also halting development of two ...
Discover outperforming stocks and invest smarter with Top Smart Score StocksFilter, analyze, and streamline your ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback